The expanding clinical and genetic spectrum of ATP1A3-related disorders

Objective: We aimed to delineate the clinical and genetic spectrum of ATP1A3-related disorders and recognition of a potential genotype-phenotype correlation. Methods: We identified 16 new patients with alternating hemiplegia of childhood (AHC) and 3 new patients with rapid-onset dystonia-parkinsonism (RDP) and included these as well as the clinical and molecular findings of all previously reported 164 patients with mutation-positive AHC and RDP in our analyses. Results: Major clinical characteristics shared in common by AHC and RDP comprise a strikingly asymmetric, predominantly dystonic movement disorder with rostrocaudal gradient of involvement and physical, emotional, or chemical stressors as triggers. The clinical courses include an early-onset polyphasic for AHC, a later-onset mono- or biphasic for RDP, as well as intermediate forms. Meta-analysis of the 8 novel and 38 published ATP1A3 mutations shows that the ones affecting transmembrane and functional domains tend to be associated with AHC as the more severe phenotype. The majority of mutations are located in exons 8, 14, 17, and 18. Conclusion: AHC and RDP constitute clinical prototypes in a continuous phenotypic spectrum of ATP1A3-related disorders. Intermediate phenotypes combining criteria of both conditions are increasingly recognized. Efficient stepwise mutation analysis of the ATP1A3 gene may prioritize those exons where current state of knowledge indicates mutational clusters.

[1]  S. Bressman,et al.  Rapid‐onset dystonia‐parkinsonism in a second family , 1997, Neurology.

[2]  P. Ullner,et al.  GLUT1 DEFICIENCY AND ALTERNATING HEMIPLEGIA OF CHILDHOOD , 2009, Neurology.

[3]  T Gasser,et al.  NOVEL ATP1A3 MUTATION IN A SPORADIC RDP PATIENT WITH MINIMAL BENEFIT FROM DEEP BRAIN STIMULATION , 2008, Neurology.

[4]  Emmanuel Roze,et al.  [123I]-FP-CIT and [99mTc]-HMPAO single photon emission computed tomography in a new sporadic case of rapid-onset dystonia–parkinsonism , 2008, Journal of the Neurological Sciences.

[5]  M. Stacy,et al.  New triggers and non-motor findings in a family with rapid-onset dystonia-parkinsonism. , 2012, Parkinsonism & related disorders.

[6]  X. Breakefield,et al.  Rapid‐onset dystonia‐parkinsonism , 1993, Neurology.

[7]  B. Vilsen,et al.  Mutations Phe785Leu and Thr618Met in Na+,K+-ATPase, Associated with Familial Rapid-onset Dystonia Parkinsonism, Interfere with Na+ Interaction by Distinct Mechanisms* , 2006, Journal of Biological Chemistry.

[8]  Christine Klein,et al.  Rapid-onset dystonia-parkinsonism: case report , 2010, Journal of Neurology.

[9]  L. Ozelius,et al.  RAPID-ONSET DYSTONIA-PARKINSONISM IN A CHILD WITH A NOVEL ATP1A3 GENE MUTATION , 2009, Neurology.

[10]  S. Tsuji,et al.  Identification of ATP1A3 Mutations by Exome Sequencing as the Cause of Alternating Hemiplegia of Childhood in Japanese Patients , 2013, PloS one.

[11]  D. Tarsy,et al.  Case records of the Massachusetts General Hospital. Case 17-2010 - a 29-year-old woman with flexion of the left hand and foot and difficulty speaking. , 2010, The New England journal of medicine.

[12]  L. Ozelius.  Clinical spectrum of disease associated with ATP1A3 mutations , 2012, The Lancet Neurology.

[13]  William B Dobyns,et al.  Mutations in the Na+/K+-ATPase α3 Gene ATP1A3 Are Associated with Rapid-Onset Dystonia Parkinsonism , 2004, Neuron.

[14]  David B. Goldstein,et al.  De novo mutations in ATP1A3 cause alternating hemiplegia of childhood , 2012, Nature Genetics.

[15]  J. Aicardi,et al.  Alternating hemiplegia of childhood. , 1993, The Journal of pediatrics.

[16]  L. Ozelius,et al.  Rapid‐onset dystonia–parkinsonism: A fourth family consistent with linkage to chromosome 19q13 , 2004, Movement disorders : official journal of the Movement Disorder Society.

[17]  N. Van Blercom,et al.  Possible sporadic rapid‐onset dystonia–parkinsonism , 2002, Movement disorders : official journal of the Movement Disorder Society.

[18]  Alexander Münchau,et al.  The phenotypic spectrum of rapid-onset dystonia-parkinsonism (RDP) and mutations in the ATP1A3 gene. , 2007, Brain : a journal of neurology.

[19]  Allison Brashear,et al.  ATP1A3 mutations in infants: a new rapid‐onset dystonia–Parkinsonism phenotype characterized by motor delay and ataxia , 2012, Developmental medicine and child neurology.

[20]  Paul Casaer,et al.  Evidence of a non-progressive course of alternating hemiplegia of childhood: study of a large cohort of children and adults. , 2010, Brain : a journal of neurology.

[21]  Case 17-2010 , 2010 .

[22]  M. Dobretsov,et al.  Neuronal function and alpha3 isoform of the Na/K-ATPase. , 2005, Frontiers in bioscience : a journal and virtual library.

[23]  A. Lees,et al.  Sporadic rapid‐onset dystonia–parkinsonism presenting as Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[24]  L. Ozelius,et al.  ATP1A3 mutation in the first asian case of rapid‐onset dystonia‐parkinsonism , 2007, Movement disorders : official journal of the Movement Disorder Society.

[25]  O. Hardiman,et al.  Rapid-onset dystonia-parkinsonism , 2000, Neurology.

[26]  Birgit Zirn,et al.  Heterozygous de-novo mutations in ATP1A3 in patients with alternating hemiplegia of childhood: a whole-exome sequencing gene-identification study , 2012, The Lancet Neurology.

[27]  M. Stacy,et al.  Psychiatric disorders in rapid-onset dystonia-parkinsonism , 2012, Neurology.

[28]  M. Vidailhet,et al.  The multiple faces of the ATP1A3‐related dystonic movement disorder , 2013, Movement disorders : official journal of the Movement Disorder Society.

[29]  Hugo Gutiérrez-de-Terán,et al.  A C-terminal mutation of ATP1A3 underscores the crucial role of sodium affinity in the pathophysiology of rapid-onset dystonia-parkinsonism. , 2009, Human molecular genetics.